SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Treasure Global, Inc. engages in the provision of payment solutions. The firm created an online-to-offline (O2O) e-commerce platform business model offering consumers and merchants instant rebates and affiliate cashback programs. It operates through the ZCITY Platform and Customized Software Development Service segments. The company was founded by Kok Pin Tan on March 20, 2020 and is headquartered in New York, NY.

Treasure Global Inc

TREASURE GLOBAL INC

TGL is experiencing significant volatility and trending due to a recent reverse stock split and renewed growth roadmap. Community discussions revolve around the potential for a short squeeze, comparing it to similar plays like $SMX. With a low float and high short interest, the stock is seeing explosive intraday movement, sparking debates about its potential trajectory and sustainability.

Pump Mind Virus is a Pure Meme with a long term vision. We are building for the future while making no promises about the present. The project aims to bring the spirit of community memes back to the Solana ecosystem. We do that with engaging content and memes. Culture through community. Viral spread by word of mouth.  And most importantly, by not using the fake hype machine that has come to dominate the meme coin landscape.

PumpMindVirus

PumpMindVirus ($PMV) is trending as its community rallies around a meme-driven, "infected" culture, fostering strong engagement and shared enthusiasm. Discussions highlight the token's meme-based appeal within the $SOL ecosystem and the community's dedication to spreading awareness. The community emphasizes its meme-focused identity while expressing excitement for future goals.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana's stock is trending amid discussions of its potential inclusion in the S&P 500, leading to a surge in price. The community is debating whether the company's fundamentals justify its high valuation and recent gains, with some suggesting possible market manipulation. Others point to the potential benefits of the S&P 500 inclusion for the stock.

Wheeler Real Estate Investment Trust, Inc. engages in the acquisition, finance, development, lease, ownership, and management of retail properties. Its property portfolio includes income producing, strip centers, neighborhood, grocery-anchored, community, and free-standing retail properties. The company was founded on June 23, 2011 and is headquartered in Virginia Beach, VA.

Wheeler Real Estate Investment Trust Inc

WHLR is trending due to significant intraday volatility and a massive surge in trading volume, reminiscent of other recent low-float runners like $SMX and $TGL. The community is actively discussing potential short squeezes, dilution concerns, and price targets, while weighing the company's fundamentals against its speculative potential. Some traders believe WHLR could see substantial gains, citing its small float and asset value, while others are wary of potential share dumping.

Pump.fun

Pump.fun's native token, $PUMP, is trending as community members highlight its strong community and meme culture. The community emphasizes its resilience, with some suggesting a potential breakout is coming, as well as pointing to a large whale scooping up a significant amount of tokens. Discussions also involve projects building within the pump.fun ecosystem on Solana ($SOL). 

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending following the company's decision to file for PDUFA after SOL-1 readout, rather than waiting for SOL-R results, indicating strong confidence in initial data. The community is discussing the implications of this move, including potential accelerated timelines and the possibility of a Monday morning press release. Some are speculating about potential buyouts and comparing OCUL to competitors in the eye care market.

Jiayin Group, Inc. engages in the operation of an online individual finance marketplace in China, which connects individual investors and individual borrowers. The company was founded by Dinggui Yan in 2011 and is headquartered in Shanghai, China.

Jiayin Group Inc - ADR

Jiayin Group Inc.

Jiayin Group (JFIN) is trending due to positive community sentiment around its strong financials, dividend, and potential for growth within the Chinese fintech sector. Discussions highlight the stock's undervaluation compared to its peers, with some traders believing it's poised for a significant rebound. Despite some volatility and mixed opinions, the focus remains on JFIN's earnings, dividend prospects, and potential institutional interest.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

BDRX is trending amid discussions around its low float and potential for a squeeze, with some traders drawing comparisons to previous high-momentum stocks. The community is analyzing recent trading volume and monitoring for news catalysts, with some mentioning its Phase 3 trial for FAP and potential market opportunity. Discussions also include mention of potential reverse splits.

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Clene Inc

CLNN is trending due to community discussion surrounding a recent Form 144 filing indicating a potential insider sale, sparking debates about Symbiosis Capital Partners exiting their position and possible dilutive events. Some investors believe the recent price drop is an overreaction and an opportunity to buy, while others express concern over potential dilution and the company's cash runway. Despite the uncertainty, positive long-term survival data and potential FDA approval for ALS treatment are still key talking points.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Despite a massive volume spike, NFLX is trending down, driven by concerns surrounding a potential acquisition of Warner Bros. Discovery and the significant debt it could incur. The community is debating the merits of the deal, with some seeing it as a strategic move to dominate streaming, while others fear regulatory hurdles and financial strain.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Shkreli said that he would join the company as CEO if President Trump allowed it.</li><li>QCLS was formerly known as TNF Pharmaceuticals and announced a name change in September 2025 as it pivoted to become a quantum-class computing company.</li></ul>Q/C Technologies Inc. (QCLS) shares soared over 60% on Thursday, extending Wednesday’s gains as American pharma investor Martin Shkreli announced that he had purchased the company’s shares.“We bought a photonic/optical computing stock: $QCLS. I'm convinced that the answer to frontier computing is optical, not quantum. we're calling it "quantum class" so investors understand it,” Shkreli said in a post on X. He also added that he would join the company as CEO if President Trump allowed it.Shkreli also noted that his near-term target on the stock is $100. Currently, QCLS shares are trading around $7.<figure class="image"><a class="st-link-external" href="https://x.com/MartinShkreli/status/1996225504416792760" target="_blank" rel="noopener noreferrer nofollow"><img style="aspect-ratio:1171/488;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_9_37_05_PM_png_4d4226b6e5.webp" alt="Shkreli said on X that he bought QCLS." width="1171" height="488"></a></figure><h2 class="st-heading-2"> Quantum Leaps</h2>Shkreli said that photonic technology delivers on the promise of quantum computing with realistic capabilities, while matrix multiplication could be far faster than GPUs.QCLS was formerly known as TNF Pharmaceuticals, Inc. (TNFA). The company announced a name change in September to represent its strategic pivot from pharmaceuticals to quantum-class computing.In October, the company obtained exclusive global digital rights to LightSolver’s laser processing unit (LPU) that can be used in the cryptocurrency verticals.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment for the stock was ‘extremely bullish’ while message volume jumped to ‘extremely high’ at the time of writing. The stock was also the second-most-trending ticker on the platform.<figure class="image"><img style="aspect-ratio:1281/156;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_10_04_48_PM_png_ecefdba5d2.webp" alt="On Stocktwits, retail sentiment was ‘extremely bullish’ while message volume jumped to ‘extremely high’." width="1281" height="156"></figure>One user highlighted their positive take on the stock.<stembedurl>https://stocktwits.com/BullishBee/message/638169244</stembedurl>Another user noted that the stock was ready for another rally.<stembedurl>https://stocktwits.com/RM7391/message/638168492</stembedurl>Shares of QCLS are down over 98% year-to-date.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/brr-stock-jumps-after-ceo-pompiliano-accepts-1-salary-with-stock-incentives/cLIiP4NREjB">BRR Stock Jumps After CEO Anthony Pompiliano Accepts $1 Salary With Stock Incentives</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

Quantum Computing, Quantum Physics, Quantum mechanics, Science, Technology. (Representative image courtesy of Just_Super via Getty Images)

Why Did QCLS Stock Surge Over 60% Today?

QCLS shares rallied after American pharma investor Martin Shkreli said on X that he had bought the stock, giving it a near-term price target of $100. 

Equity

<ul class="summary-bullets"><li>The stake sale comes on the heels of the company increasing its stake in TNF Pharmaceuticals in September by an additional $3 million.&nbsp;</li><li>PharmaCyte said that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.&nbsp;</li><li>The company said that monetizing its stake in Femasys will help strengthen its financial position.</li></ul> PharmaCyte Biotech, Inc. (PMCB) said on Tuesday that it sold its stake in Femasys Inc. (FEMY), thereby increasing its cash and marketable securities to about $20 million.The company had cash and marketable securities of only about $13.3 million as of the end of July. The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.pharmacyte.com/press-releases/detail/319/pharmacyte-biotech-successfully-monetizes-femasys-stake">said</a> that monetizing its stake in Femasys will help strengthen its financial position.Shares of <a href="https://stocktwits.com/symbol/PMCB">PMCB </a>traded 25% higher at the time of writing.<h2 class="st-heading-2">PharmaCyte’s Financial Position</h2>CEO Josh Silverman stated that the successful monetization of the Femasys position demonstrates the effectiveness of the strategic and disciplined capital allocation approach. “We are committed to deploying shareholder capital intelligently, balancing near-term returns with opportunities that can deliver sustained value creation,” he said.Overall, PharmaCyte now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash. The company highlighted its low stock price below $1 and added that it plans to continue pursuing value-accretive investment opportunities and disciplined operational management.The stake sale comes on the heels of the company increasing its stake in Q/C Technologies, formerly known as TNF Pharmaceuticals, in September by an additional $3 million.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around PMCB jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.A Stocktwits user opined that the news shows the company has ways to generate cash without doing share offerings.<stembedurl>https://stocktwits.com/MadBat/message/637404061</stembedurl>Another expects the stock to cross the $1 threshold.<stembedurl>https://stocktwits.com/cbt2020/message/637412358</stembedurl>PMCB stock fell 48% this year and by about 53% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/nio-stock-slips-after-q4-revenue-guidance-disappoints/cL52NcEREgI">Nio Stock Slips After Q4 Revenue Guidance Disappoints</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

PMCB Stock Jumps 25% After Company Sells Stake In Femasys

PharmaCyte noted that it now has approximately $25 million in marketable securities, in addition to roughly $20 million in cash.

Q/C Technologies, Inc. (QCLS) stock surged 15% in the premarket session and became the top trending ticker among equities on Stocktwits on Friday morning. The stock is on its way toward the $6 mark, last seen in August this year.The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space. Momentum around quantum computing, triggered by recent&nbsp;advancements in both quantum hardware and software, along with efforts to build more powerful quantum machines, also helped build interest around the stock.Formerly known as&nbsp;TNF Pharmaceuticals Inc., the company changed its name to Q/C Technologies to reflect its focus towards quantum-class computing, catering to crypto and blockchain applications.Retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/QCLS">Q/C Technologies' stock</a>&nbsp;jumped to ‘extremely bullish’ from ‘neutral’ territory the previous day. Message volume improved to ‘extremely high’ from ‘low’ levels in 24 hours.&nbsp;On September 24, the company stated that it secured exclusive worldwide rights to a laser-based processor developed by LightSolver. This light-speed laser processing unit (LPU) boosts computing by leveraging the speed and efficiency of photons over traditional semiconductor methods.LightSolver’s LPU is said to reduce power usage by up to 90% while outperforming current graphics processing units (GPUs) and quantum computing platforms in both speed and reliability. In addition to performance improvements, the system provides enhanced security for blockchain networks, a feature of growing importance for decentralized finance and cryptocurrency protocols.Q/C Technologies’ stock has lost over 96% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/howard-lutnick-pushes-back-on-nvidia-uae-ai-chip-deal-report-says/chCu4zUR3fi">Howard Lutnick Pushes Back On Nvidia’s Multi-Billion-Dollar UAE AI Chip Deal? Report Says Delay Leaves Jensen Huang Frustrated</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A quantum computer being built by the start-up IQM Germany is located in a data center.

QCLS Stock Surges 15% In Pre-Market Today, Inches Closer To $6 Mark 

The stock has garnered significant retail attention in recent days following the firm's announcement of a shift in focus to high-performance computing tailored for the cryptocurrency space. 

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

$SOFI

$RDDT

$CVNA

$MSTR

Which stock do you think gets added to the S&amp;P 500 in today’s rebalance?

Stocktwits

Which stock do you think gets added to the S&P 500 in today’s rebalance?

QCLS
Q/C Technologies Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest QCLS News

QCLSQ/C Technologies Inc.